4148 — All Cosmos Bio-Tech Holding Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD3.20bn
- TWD2.73bn
- TWD2.83bn
- 64
- 59
- 71
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 104 | 150 | 322 | 634 | 258 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 53.9 | -21 | -43.5 | 33.8 | -39.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 673 | -306 | -394 | -673 | 692 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 884 | -127 | -67.6 | 43.8 | 959 |
Capital Expenditures | -39.2 | -35.2 | -104 | -60.9 | -163 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -245 | 167 | -4.32 | 56.2 | -39.6 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -284 | 132 | -108 | -4.67 | -203 |
Financing Cash Flow Items | 15.4 | -1.32 | -2.18 | -12.2 | 12.4 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -344 | -46.1 | 196 | 490 | -550 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 246 | -75.8 | -21.4 | 601 | 117 |